Document is current

Any future updates will be listed below

HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report

Crossref DOI link: https://doi.org/10.1007/s00384-015-2448-7

Published Online: 2015-11-12

Published Print: 2016-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark